ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Zentel, Suspension zum Einnehmen - 10 ml
49749023 GlaxoSmithKline AG
Zentel, Suspension zum Einnehmen28.12.1993
  28.12.1993
Albendazole (P02CA03)05.11.2007
WHO-DDD 
08.05.10.10 ml
08.05.10. 
B  
No 
IPCI
3.08  
k.A.7.65
7680497490237Synthetika
  
Composition
albendazolum 400 mg, magnesii aluminii silicas, carmellosum natricum, glycerolum (85 per centum), polysorbatum 80, sorbitani lauras, simeticonum, polysorbatum 65, methylcellulosum, macrogoli stearas, glyceroli monostearas 40-55, xanthani gummi, acidum sulfuricum, saccharinum natricum, aromatica Vanille cum alcohol benzylicus 2.2 mg et propylenglycolum 3.8 mg, aromatica Orangen, aromatica Passionsfrucht, E 200, E 202, E 210 20 mg, aqua purificata q.s. ad suspensionem pro 10 ml corresp. natrium 4.2 mg.
Packungsbestandteile
Suspension (oral)
 
 
Active AgentDose
Albendazole400mg / 10ml
 
Inactive agentsDoseadditional_information
Sulfuric Acid  
Aqua Purificata  
Aromatica (Orangen)  
Aromatica (Vanille) cum Alcohol Benzylicus2.2mg / 10ml 
Aromatica Passionsfrucht  
Carmellose Sodium  
E 200 conserv.
E 202 conserv.
E 21020mg / 10mlconserv.
Glyceroli Monostearas40-55 
Glycerol  
Macrogoli Stearas  
Magnesii Aluminii Silicas  
Methylcellulosum  
Polysorbatum 65  
Polysorbatum 80  
Propylenglycol3.8mg / 10ml 
Saccharinum Natricum  
Simeticone  
Sorbitani Lauras  
Xanthani Gummi  
Source
Data was imported : 06.11.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home